Drug-associative bullous pemphigoid (DABP) is a term used to describe instances of bullous pemphigoid demonstrating clinical, histological, or immunourlological features identical or similar to those of the idiourlic form of bullous pemphigoid, related to the systemic ingestion, or topical application.